Global RNA-Based Therapeutics and Vaccines Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 16-Jul-2021
No. of pages: 109
Inquire Before Buying

RNA-based biopharmaceuticals, which includes therapeutics and vaccines, is a relatively new class of treatment and prophylactic for a number of chronic and rare diseases, including cancer, diabetes, tuberculosis and certaincardiovascular conditions.

RNA-based biopharmaceuticals are a relatively new class of therapies that are demonstrating significant growth and potential for the treatment and prevention of chronic and rare diseases.

Market Analysis and Insights: Global RNA-Based Therapeutics and Vaccines Market

The global RNA-Based Therapeutics and Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global RNA-Based Therapeutics and Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global RNA-Based Therapeutics and Vaccines market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global RNA-Based Therapeutics and Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global RNA-Based Therapeutics and Vaccines market.

Global RNA-Based Therapeutics and Vaccines Scope and Market Size

RNA-Based Therapeutics and Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global RNA-Based Therapeutics and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- RNA-Based Therapeutics

- RNA-Based Vaccines

Segment by Application

- Oncology

- Immunology

- Ophthalmology

- Cardiovascular Diseases

- Infectious Diseases

- Genetic Diseases

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Alnylam Pharmaceuticals

- Arbutus Biopharma

- Arrowhead Pharmaceuticals

- BioNTech

- CureVac

- Dicerna Pharmaceuticals

- Regulus Therapeutics

- Marina Biotech

- MiRagen Therapeutics

- Moderna Therapeutics

- Quark Pharmaceuticals

- Roche

- Sylentis

Global RNA-Based Therapeutics and Vaccines Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 RNA-Based Therapeutics
1.2.3 RNA-Based Vaccines
1.3 Market by Application
1.3.1 Global RNA-Based Therapeutics and Vaccines Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncology
1.3.3 Immunology
1.3.4 Ophthalmology
1.3.5 Cardiovascular Diseases
1.3.6 Infectious Diseases
1.3.7 Genetic Diseases
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global RNA-Based Therapeutics and Vaccines Market Perspective (2016-2027)
2.2 RNA-Based Therapeutics and Vaccines Growth Trends by Regions
2.2.1 RNA-Based Therapeutics and Vaccines Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 RNA-Based Therapeutics and Vaccines Historic Market Share by Regions (2016-2021)
2.2.3 RNA-Based Therapeutics and Vaccines Forecasted Market Size by Regions (2022-2027)
2.3 RNA-Based Therapeutics and Vaccines Industry Dynamic
2.3.1 RNA-Based Therapeutics and Vaccines Market Trends
2.3.2 RNA-Based Therapeutics and Vaccines Market Drivers
2.3.3 RNA-Based Therapeutics and Vaccines Market Challenges
2.3.4 RNA-Based Therapeutics and Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA-Based Therapeutics and Vaccines Players by Revenue
3.1.1 Global Top RNA-Based Therapeutics and Vaccines Players by Revenue (2016-2021)
3.1.2 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Players (2016-2021)
3.2 Global RNA-Based Therapeutics and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by RNA-Based Therapeutics and Vaccines Revenue
3.4 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio
3.4.1 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA-Based Therapeutics and Vaccines Revenue in 2020
3.5 RNA-Based Therapeutics and Vaccines Key Players Head office and Area Served
3.6 Key Players RNA-Based Therapeutics and Vaccines Product Solution and Service
3.7 Date of Enter into RNA-Based Therapeutics and Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA-Based Therapeutics and Vaccines Breakdown Data by Type
4.1 Global RNA-Based Therapeutics and Vaccines Historic Market Size by Type (2016-2021)
4.2 Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Type (2022-2027)
5 RNA-Based Therapeutics and Vaccines Breakdown Data by Application
5.1 Global RNA-Based Therapeutics and Vaccines Historic Market Size by Application (2016-2021)
5.2 Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America RNA-Based Therapeutics and Vaccines Market Size (2016-2027)
6.2 North America RNA-Based Therapeutics and Vaccines Market Size by Type
6.2.1 North America RNA-Based Therapeutics and Vaccines Market Size by Type (2016-2021)
6.2.2 North America RNA-Based Therapeutics and Vaccines Market Size by Type (2022-2027)
6.2.3 North America RNA-Based Therapeutics and Vaccines Market Size by Type (2016-2027)
6.3 North America RNA-Based Therapeutics and Vaccines Market Size by Application
6.3.1 North America RNA-Based Therapeutics and Vaccines Market Size by Application (2016-2021)
6.3.2 North America RNA-Based Therapeutics and Vaccines Market Size by Application (2022-2027)
6.3.3 North America RNA-Based Therapeutics and Vaccines Market Size by Application (2016-2027)
6.4 North America RNA-Based Therapeutics and Vaccines Market Size by Country
6.4.1 North America RNA-Based Therapeutics and Vaccines Market Size by Country (2016-2021)
6.4.2 North America RNA-Based Therapeutics and Vaccines Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe RNA-Based Therapeutics and Vaccines Market Size (2016-2027)
7.2 Europe RNA-Based Therapeutics and Vaccines Market Size by Type
7.2.1 Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2016-2021)
7.2.2 Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2022-2027)
7.2.3 Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2016-2027)
7.3 Europe RNA-Based Therapeutics and Vaccines Market Size by Application
7.3.1 Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2016-2021)
7.3.2 Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2022-2027)
7.3.3 Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2016-2027)
7.4 Europe RNA-Based Therapeutics and Vaccines Market Size by Country
7.4.1 Europe RNA-Based Therapeutics and Vaccines Market Size by Country (2016-2021)
7.4.2 Europe RNA-Based Therapeutics and Vaccines Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size (2016-2027)
8.2 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Type
8.2.1 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Type (2016-2021)
8.2.2 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Type (2022-2027)
8.2.3 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Type (2016-2027)
8.3 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Application
8.3.1 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Application (2016-2021)
8.3.2 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Application (2022-2027)
8.3.3 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Application (2016-2027)
8.4 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Region
8.4.1 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Region (2016-2021)
8.4.2 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America RNA-Based Therapeutics and Vaccines Market Size (2016-2027)
9.2 Latin America RNA-Based Therapeutics and Vaccines Market Size by Type
9.2.1 Latin America RNA-Based Therapeutics and Vaccines Market Size by Type (2016-2021)
9.2.2 Latin America RNA-Based Therapeutics and Vaccines Market Size by Type (2022-2027)
9.2.3 Latin America RNA-Based Therapeutics and Vaccines Market Size by Type (2016-2027)
9.3 Latin America RNA-Based Therapeutics and Vaccines Market Size by Application
9.3.1 Latin America RNA-Based Therapeutics and Vaccines Market Size by Application (2016-2021)
9.3.2 Latin America RNA-Based Therapeutics and Vaccines Market Size by Application (2022-2027)
9.3.3 Latin America RNA-Based Therapeutics and Vaccines Market Size by Application (2016-2027)
9.4 Latin America RNA-Based Therapeutics and Vaccines Market Size by Country
9.4.1 Latin America RNA-Based Therapeutics and Vaccines Market Size by Country (2016-2021)
9.4.2 Latin America RNA-Based Therapeutics and Vaccines Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size (2016-2027)
10.2 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Type
10.2.1 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Type (2016-2021)
10.2.2 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Type (2022-2027)
10.2.3 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Type (2016-2027)
10.3 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Application
10.3.1 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Application (2016-2021)
10.3.2 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Application (2022-2027)
10.3.3 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Application (2016-2027)
10.4 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Country
10.4.1 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Country (2016-2021)
10.4.2 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Details
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021)
11.1.5 Alnylam Pharmaceuticals Recent Development
11.2 Arbutus Biopharma
11.2.1 Arbutus Biopharma Company Details
11.2.2 Arbutus Biopharma Business Overview
11.2.3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Introduction
11.2.4 Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021)
11.2.5 Arbutus Biopharma Recent Development
11.3 Arrowhead Pharmaceuticals
11.3.1 Arrowhead Pharmaceuticals Company Details
11.3.2 Arrowhead Pharmaceuticals Business Overview
11.3.3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
11.3.4 Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021)
11.3.5 Arrowhead Pharmaceuticals Recent Development
11.4 BioNTech
11.4.1 BioNTech Company Details
11.4.2 BioNTech Business Overview
11.4.3 BioNTech RNA-Based Therapeutics and Vaccines Introduction
11.4.4 BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021)
11.4.5 BioNTech Recent Development
11.5 CureVac
11.5.1 CureVac Company Details
11.5.2 CureVac Business Overview
11.5.3 CureVac RNA-Based Therapeutics and Vaccines Introduction
11.5.4 CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021)
11.5.5 CureVac Recent Development
11.6 Dicerna Pharmaceuticals
11.6.1 Dicerna Pharmaceuticals Company Details
11.6.2 Dicerna Pharmaceuticals Business Overview
11.6.3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
11.6.4 Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021)
11.6.5 Dicerna Pharmaceuticals Recent Development
11.7 Regulus Therapeutics
11.7.1 Regulus Therapeutics Company Details
11.7.2 Regulus Therapeutics Business Overview
11.7.3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Introduction
11.7.4 Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021)
11.7.5 Regulus Therapeutics Recent Development
11.8 Marina Biotech
11.8.1 Marina Biotech Company Details
11.8.2 Marina Biotech Business Overview
11.8.3 Marina Biotech RNA-Based Therapeutics and Vaccines Introduction
11.8.4 Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021)
11.8.5 Marina Biotech Recent Development
11.9 MiRagen Therapeutics
11.9.1 MiRagen Therapeutics Company Details
11.9.2 MiRagen Therapeutics Business Overview
11.9.3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Introduction
11.9.4 MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021)
11.9.5 MiRagen Therapeutics Recent Development
11.10 Moderna Therapeutics
11.10.1 Moderna Therapeutics Company Details
11.10.2 Moderna Therapeutics Business Overview
11.10.3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Introduction
11.10.4 Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021)
11.10.5 Moderna Therapeutics Recent Development
11.11 Quark Pharmaceuticals
11.11.1 Quark Pharmaceuticals Company Details
11.11.2 Quark Pharmaceuticals Business Overview
11.11.3 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
11.11.4 Quark Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021)
11.11.5 Quark Pharmaceuticals Recent Development
11.12 Roche
11.12.1 Roche Company Details
11.12.2 Roche Business Overview
11.12.3 Roche RNA-Based Therapeutics and Vaccines Introduction
11.12.4 Roche Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021)
11.12.5 Roche Recent Development
11.13 Sylentis
11.13.1 Sylentis Company Details
11.13.2 Sylentis Business Overview
11.13.3 Sylentis RNA-Based Therapeutics and Vaccines Introduction
11.13.4 Sylentis Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021)
11.13.5 Sylentis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of RNA-Based Therapeutics
Table 3. Key Players of RNA-Based Vaccines
Table 4. Global RNA-Based Therapeutics and Vaccines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global RNA-Based Therapeutics and Vaccines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global RNA-Based Therapeutics and Vaccines Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global RNA-Based Therapeutics and Vaccines Market Share by Regions (2016-2021)
Table 8. Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global RNA-Based Therapeutics and Vaccines Market Share by Regions (2022-2027)
Table 10. RNA-Based Therapeutics and Vaccines Market Trends
Table 11. RNA-Based Therapeutics and Vaccines Market Drivers
Table 12. RNA-Based Therapeutics and Vaccines Market Challenges
Table 13. RNA-Based Therapeutics and Vaccines Market Restraints
Table 14. Global RNA-Based Therapeutics and Vaccines Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global RNA-Based Therapeutics and Vaccines Market Share by Players (2016-2021)
Table 16. Global Top RNA-Based Therapeutics and Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA-Based Therapeutics and Vaccines as of 2020)
Table 17. Ranking of Global Top RNA-Based Therapeutics and Vaccines Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by RNA-Based Therapeutics and Vaccines Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players RNA-Based Therapeutics and Vaccines Product Solution and Service
Table 21. Date of Enter into RNA-Based Therapeutics and Vaccines Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global RNA-Based Therapeutics and Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 24. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Type (2016-2021)
Table 25. Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global RNA-Based Therapeutics and Vaccines Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Application (2016-2021)
Table 29. Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America RNA-Based Therapeutics and Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 32. North America RNA-Based Therapeutics and Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America RNA-Based Therapeutics and Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 34. North America RNA-Based Therapeutics and Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America RNA-Based Therapeutics and Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America RNA-Based Therapeutics and Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe RNA-Based Therapeutics and Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe RNA-Based Therapeutics and Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America RNA-Based Therapeutics and Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America RNA-Based Therapeutics and Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America RNA-Based Therapeutics and Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America RNA-Based Therapeutics and Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America RNA-Based Therapeutics and Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America RNA-Based Therapeutics and Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 61. Alnylam Pharmaceuticals Company Details
Table 62. Alnylam Pharmaceuticals Business Overview
Table 63. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Product
Table 64. Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021) & (US$ Million)
Table 65. Alnylam Pharmaceuticals Recent Development
Table 66. Arbutus Biopharma Company Details
Table 67. Arbutus Biopharma Business Overview
Table 68. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Product
Table 69. Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021) & (US$ Million)
Table 70. Arbutus Biopharma Recent Development
Table 71. Arrowhead Pharmaceuticals Company Details
Table 72. Arrowhead Pharmaceuticals Business Overview
Table 73. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Product
Table 74. Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021) & (US$ Million)
Table 75. Arrowhead Pharmaceuticals Recent Development
Table 76. BioNTech Company Details
Table 77. BioNTech Business Overview
Table 78. BioNTech RNA-Based Therapeutics and Vaccines Product
Table 79. BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021) & (US$ Million)
Table 80. BioNTech Recent Development
Table 81. CureVac Company Details
Table 82. CureVac Business Overview
Table 83. CureVac RNA-Based Therapeutics and Vaccines Product
Table 84. CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021) & (US$ Million)
Table 85. CureVac Recent Development
Table 86. Dicerna Pharmaceuticals Company Details
Table 87. Dicerna Pharmaceuticals Business Overview
Table 88. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Product
Table 89. Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021) & (US$ Million)
Table 90. Dicerna Pharmaceuticals Recent Development
Table 91. Regulus Therapeutics Company Details
Table 92. Regulus Therapeutics Business Overview
Table 93. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Product
Table 94. Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021) & (US$ Million)
Table 95. Regulus Therapeutics Recent Development
Table 96. Marina Biotech Company Details
Table 97. Marina Biotech Business Overview
Table 98. Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021) & (US$ Million)
Table 99. Marina Biotech Recent Development
Table 100. MiRagen Therapeutics Company Details
Table 101. MiRagen Therapeutics Business Overview
Table 102. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Product
Table 103. MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021) & (US$ Million)
Table 104. MiRagen Therapeutics Recent Development
Table 105. Moderna Therapeutics Company Details
Table 106. Moderna Therapeutics Business Overview
Table 107. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Product
Table 108. Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021) & (US$ Million)
Table 109. Moderna Therapeutics Recent Development
Table 110. Quark Pharmaceuticals Company Details
Table 111. Quark Pharmaceuticals Business Overview
Table 112. Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Product
Table 113. Quark Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021) & (US$ Million)
Table 114. Quark Pharmaceuticals Recent Development
Table 115. Roche Company Details
Table 116. Roche Business Overview
Table 117. Roche RNA-Based Therapeutics and Vaccines Product
Table 118. Roche Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021) & (US$ Million)
Table 119. Roche Recent Development
Table 120. Sylentis Company Details
Table 121. Sylentis Business Overview
Table 122. Sylentis RNA-Based Therapeutics and Vaccines Product
Table 123. Sylentis Revenue in RNA-Based Therapeutics and Vaccines Business (2016-2021) & (US$ Million)
Table 124. Sylentis Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNA-Based Therapeutics and Vaccines Market Share by Type: 2020 VS 2027
Figure 2. RNA-Based Therapeutics Features
Figure 3. RNA-Based Vaccines Features
Figure 4. Global RNA-Based Therapeutics and Vaccines Market Share by Application: 2020 VS 2027
Figure 5. Oncology Case Studies
Figure 6. Immunology Case Studies
Figure 7. Ophthalmology Case Studies
Figure 8. Cardiovascular Diseases Case Studies
Figure 9. Infectious Diseases Case Studies
Figure 10. Genetic Diseases Case Studies
Figure 11. Others Case Studies
Figure 12. RNA-Based Therapeutics and Vaccines Report Years Considered
Figure 13. Global RNA-Based Therapeutics and Vaccines Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global RNA-Based Therapeutics and Vaccines Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global RNA-Based Therapeutics and Vaccines Market Share by Regions: 2020 VS 2027
Figure 16. Global RNA-Based Therapeutics and Vaccines Market Share by Regions (2022-2027)
Figure 17. Global RNA-Based Therapeutics and Vaccines Market Share by Players in 2020
Figure 18. Global Top RNA-Based Therapeutics and Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA-Based Therapeutics and Vaccines as of 2020
Figure 19. The Top 10 and 5 Players Market Share by RNA-Based Therapeutics and Vaccines Revenue in 2020
Figure 20. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Type (2016-2021)
Figure 21. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Type (2022-2027)
Figure 22. North America RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America RNA-Based Therapeutics and Vaccines Market Share by Type (2016-2027)
Figure 24. North America RNA-Based Therapeutics and Vaccines Market Share by Application (2016-2027)
Figure 25. North America RNA-Based Therapeutics and Vaccines Market Share by Country (2016-2027)
Figure 26. United States RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe RNA-Based Therapeutics and Vaccines Market Share by Type (2016-2027)
Figure 30. Europe RNA-Based Therapeutics and Vaccines Market Share by Application (2016-2027)
Figure 31. Europe RNA-Based Therapeutics and Vaccines Market Share by Country (2016-2027)
Figure 32. Germany RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Share by Type (2016-2027)
Figure 40. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Share by Application (2016-2027)
Figure 41. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Share by Region (2016-2027)
Figure 42. China RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America RNA-Based Therapeutics and Vaccines Market Share by Type (2016-2027)
Figure 50. Latin America RNA-Based Therapeutics and Vaccines Market Share by Application (2016-2027)
Figure 51. Latin America RNA-Based Therapeutics and Vaccines Market Share by Country (2016-2027)
Figure 52. Mexico RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Share by Type (2016-2027)
Figure 56. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Share by Application (2016-2027)
Figure 57. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Share by Country (2016-2027)
Figure 58. Turkey RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Alnylam Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2016-2021)
Figure 62. Arbutus Biopharma Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2016-2021)
Figure 63. Arrowhead Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2016-2021)
Figure 64. BioNTech Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2016-2021)
Figure 65. CureVac Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2016-2021)
Figure 66. Dicerna Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2016-2021)
Figure 67. Regulus Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2016-2021)
Figure 68. Marina Biotech Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2016-2021)
Figure 69. MiRagen Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2016-2021)
Figure 70. Moderna Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2016-2021)
Figure 71. Quark Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2016-2021)
Figure 72. Roche Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2016-2021)
Figure 73. Sylentis Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key
  • Global Indoor Electric Wheelchair Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 29-Jul-2021        Price: US 3480 Onwards        Pages: 109
    The Indoor Electric Wheelchair market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our lat......
  • Global Portable Lightweight Power Wheelchair Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 29-Jul-2021        Price: US 3480 Onwards        Pages: 108
    The Portable Lightweight Power Wheelchair market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According......
  • Global Powerchairs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 29-Jul-2021        Price: US 3480 Onwards        Pages: 102
    The Powerchairs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest research, t......
  • Global 3 Ply Disposable Medical Face Mask Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 29-Jul-2021        Price: US 3480 Onwards        Pages: 101
    The 3 Ply Disposable Medical Face Mask market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to......
  • Global Portable Motorized Wheelchairs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 29-Jul-2021        Price: US 3480 Onwards        Pages: 105
    The Portable Motorized Wheelchairs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our......
  • Global Motorized Wheelchair Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 29-Jul-2021        Price: US 3480 Onwards        Pages: 105
    The Motorized Wheelchair market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest re......
  • Global Disposable Medical Protective Wear Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 29-Jul-2021        Price: US 3480 Onwards        Pages: 135
    The Disposable Medical Protective Wear market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to......
  • Global Medical Safety Apparel Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 29-Jul-2021        Price: US 3480 Onwards        Pages: 132
    The Medical Safety Apparel market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest ......
  • Global Medical Protective Wear Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 29-Jul-2021        Price: US 3480 Onwards        Pages: 130
    The Medical Protective Wear market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs